# Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

> **NCT05964582** · — · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 344 (actual)

## Conditions studied

- Respiratory Syncytial Virus Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05964582
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-11
- **Primary completion:** 2024-07-02
- **Final completion:** 2024-07-02
- **Target enrollment:** 344 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05964582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05964582, "Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05964582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*